Adani Enterprises Limited vs Sudarshan Pharma Industries Ltd

A side-by-side comparison of Adani Enterprises Limited (ADANIENT) and Sudarshan Pharma Industries Ltd (SUDARSHAN) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Adani Enterprises Limited leads ADANIENT vs SUDARSHAN on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation31
  • Profitability22
  • Growth11
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

ADANIENT takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

35.12
P/E ratio
36.08
4.43
P/B ratio
5.72
0.04%
Dividend yield
0.77%
₹75.66
EPS
₹0.97

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

11.54%
Return on equity
15.03%
10.17%
Return on capital
12.78%
13.92%
EBITDA margin
7.30%
9.90%
Net margin
3.32%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

-9.82%
Revenue CAGR (3Y)
15.11%
60.17%
Profit CAGR (3Y)
49.46%

Size & financial health

ADANIENT takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹3.59L Cr
Market cap
₹874 Cr
₹1.00L Cr
Revenue
₹703 Cr
₹9,951 Cr
Net profit
₹23 Cr
1.41
Debt / equity
1.84
Adani Enterprises Limited
  • + ["Company has delivered good profit growth of 56.9% CAGR over last 5 years", "Company has delivered good sales growth of 20.5% CAGR over last 5 years"]
  • − []
Sudarshan Pharma Industries Ltd
  • + ["Company has delivered good profit growth of 50.8% CAGR over last 5 years", "Company has delivered good sales growth of 29.5% CAGR over last 5 years"]
  • − ["Stock is trading at 5.63 times its book value", "Company has a high debt to equity ratio of 1.84."]
Adani Enterprises Limited full analysis Sudarshan Pharma Industries Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.